< Back to situations

[ORGANIZATION]

Sincofarma-SP

Featured in 1 tracked story · first seen

Situations

[QUIET] [HEALTH] [BR] [KR]

Global regulatory response to GLP-1 medication use

2 clusters · 4 sources · last updated

Latest: South Korea issues safety guidelines for GLP-1 obesity drugs

Health authorities and professional organizations in Brazil and South Korea are implementing new guidelines and training to manage the increasing use of GLP-1 receptor agonists for obesity treatment. In São Paulo, healt